Peter G. Stock

MD

Transplant surgeon

Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program.

In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical. He also studies chimerism (a therapy to prevent transplant rejection that uses the donor's bone marrow cells) and pancreatic islet cell transplantation (a procedure that can allow people with type 1 diabetes to discontinue insulin therapy).

Stock received his medical training at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992.

Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies.

  • Education

    University of Illinois School of Medicine, 1982

  • Residencies

    University of Minnesota Medical Center, General Surgery, 1990

  • Fellowships

    UCSF Medical Center, Transplant Surgery, 1992

  • Board Certifications

    Surgery, American Board of Surgery

  • Academic Title

    Professor

Conditions I specialize in

  • Liver transplant

Treatments I provide

Where I see patients (3)

    My reviews

    4.8

    Overall Experience
    75 Ratings
    About our process
    Sep 25, 2024
    Dr. PETE STOCK spent almost an hour with me to solve all my entire health issues and problems. He had a very good patience to listen to all my questions, concerns, problems and issues regarding my Transplanted Liver, my troubles kidney's warning signs, my stomach issues with aching, 4 months missing for monthly Liver function tests, loss lot of weight, extreme chronic fatigue symptoms issues, extreme low immune function symptoms, and under nutrition issues with no appetite as well as difficulty to fall asleep at night. He is the only Doctor or surgeon willing to pay attention to patient's disease warning signs, health conditions with concerns, health issues needing, and promising following up treatment for the specific disease test results. He instructed me to write down his command orders in a list and instructed to contact PA name DANA to follow his command orders list. He is the only Doctor spent this kind patience and time with me. He did really care for my entire health. He told me that I could live longer than average Liver Transplant patients. He is my doctor HERO. He did the best job for my Liver Transplant . He is the best surgeon in UCSF HOSPITAL history. I wish him the best in his profession and had a long life to continue to help others patients. God bless him.
    Sep 17, 2024
    Very excellent job
    Aug 25, 2024
    Dr. Stock and Giulia Warner are the very best!
    Jun 04, 2024
    He explains the entire treatment process very well and listens to the patient calmly and answers the patient's questions.
    Mar 06, 2024
    Good
    Mar 06, 2024
    All good .
    Dec 04, 2023
    Great job from everyone
    Dec 01, 2023
    The Doctor was great Ty
    Oct 31, 2023
    Very personable. Good listener
    Oct 25, 2023
    My visit provided in depth discussion about my health and wellness with my physician. My overall test results were good and I was also able to see my liver transplant surgeon for the first time in several years.
    Sep 02, 2023
    Good
    Aug 30, 2023
    Excellent
    Aug 16, 2023
    It was ah awesome visit. All problems were discussed and answered.
    Jul 15, 2023
    My concerns were wholly addressed. Overall a comfortable informative visit.
    May 05, 2023
    I find UCSF doctors and staff personal and they make it easy and supportive
    Feb 16, 2023
    My transplant team made me feel very comfortable with my decision

    Selected research

    See all research
    Decorative Caduceus

    Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes

    Safety: Since this study is a pilot non-randomized safety and efficacy trial with patient enrollment limited by budgetary constraints, no direct statistical significance tests can be performed.

    Recruiting

    Contact me

    Share